- Home
- RELI vs INM Comparison
RELI vs INM Comparison
Compare RELI & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RELI
- INM
- Stock Information
- Founded
- RELI 2013
- INM 1981
- Country
- RELI United States
- INM Canada
- Employees
- RELI N/A
- INM N/A
- Industry
- RELI Specialty Insurers
- INM Biotechnology: Pharmaceutical Preparations
- Sector
- RELI Finance
- INM Health Care
- Exchange
- RELI Nasdaq
- INM Nasdaq
- Market Cap
- RELI 3.5M
- INM 3.2M
- IPO Year
- RELI N/A
- INM N/A
- Fundamental
- Price
- RELI $1.88
- INM $3.32
- Analyst Decision
- RELI
- INM
- Analyst Count
- RELI 0
- INM 0
- Target Price
- RELI N/A
- INM N/A
- AVG Volume (30 Days)
- RELI 3.6M
- INM 9.5M
- Earning Date
- RELI 07-24-2025
- INM 05-12-2025
- Dividend Yield
- RELI N/A
- INM N/A
- EPS Growth
- RELI N/A
- INM N/A
- EPS
- RELI N/A
- INM N/A
- Revenue
- RELI $14,208,143.00
- INM $4,920,990.00
- Revenue This Year
- RELI N/A
- INM N/A
- Revenue Next Year
- RELI N/A
- INM N/A
- P/E Ratio
- RELI N/A
- INM N/A
- Revenue Growth
- RELI 2.40
- INM N/A
- 52 Week Low
- RELI $0.97
- INM $1.72
- 52 Week High
- RELI $5.11
- INM $15.70
- Technical
- Relative Strength Index (RSI)
- RELI 61.88
- INM 59.24
- Support Level
- RELI $1.88
- INM $2.26
- Resistance Level
- RELI $2.60
- INM $5.50
- Average True Range (ATR)
- RELI 0.36
- INM 0.40
- MACD
- RELI 0.08
- INM 0.11
- Stochastic Oscillator
- RELI 52.85
- INM 37.04
About RELI Reliance Global Group Inc.
Reliance Global Group Inc operates as a holding company with diversified interests in the insurance market, as well as other related sectors. The company focuses on growing by pursuing acquisition strategies, initially and focused on wholesale and retail insurance agencies. Its primary strategies is to identify specific risks to reward arbitrage opportunities and develop these on a national platform, thereby increasing revenues and returns, and then identify and acquire undervalued wholesale and retail insurance agencies with operations in growing or underserved segments, expand and optimize their operations, and achieve asset value appreciation while generating interim cash flows. The company generates revenue in the form of commissions.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.